The Effectiveness of Add-on Treatment with Nutraceutical

QR Code

The Effectiveness of Add-on Treatment with Nutraceutical

Aim: evaluation of the effectiveness of the nutraceutical “Standard Zdorovia: Gastro” (“SZ Gastro”) in the treatment of patients with irritable bowel syndrome (IBS).Materials and methods. 52 patients (62 % women) diagnosed with IBS and IBS in combination with functional dyspepsia (FD) were included...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. T. Ivashkin, M. A. Morozova, E. A. Poluektova, O. S. Shifrin, A. G. Beniashvili, G. E. Rupchev, A. A. Alekseev, Yu. M. Poluektov, Z. A. Mamieva, A. L. Kovaleva, A. I. Ulyanin, E. A. Trush
Format:	Article
Language:	Russian
Published:	Gastro LLC 2022-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	irritable bowel syndrome functional dyspepsia dietary supplement menthol gingerol limonene treatment
Online Access:	https://www.gastro-j.ru/jour/article/view/684
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Influence of in Ovo Injection of Phytochemicals and Post-Hatch Feeding on Hatching Traits, Physiological Aspects, Productive Performance, Duodenal Morphology, and Digestibility of Broiler Chickens
by: Karrar Al-Shammari
Published: (2025-06-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

Current Prospects of Herbal STW 5 Agent in Treatment of Functional Gastrointestinal Diseases
by: A. A. Sheptulin
Published: (2022-01-01)

Dynamics of Somatic and Comorbid Mental Disorders (Distress, Anxiety, Somatisation and Depression) in Patients with Irritable Bowel Syndrome during Therapy with Alimemazine: Results of an Non-Interventional Observational Programme (“Terra”)
by: V. T. Ivashkin, et al.
Published: (2019-01-01)

Functional Disorders of the Gastrointestinal Tract During the Pandemic of a New Coronavirus Infection
by: A. A. Sheptulin, et al.
Published: (2022-09-01)

Intestinal Barrier, Permeability and Nonspecific Inflammation in Functional Gastrointestinal Disorders
by: A. L. Kovaleva, et al.
Published: (2020-09-01)

Gastroesophageal reflux disease and the functional diseases of gastro-intestinal tract: are there any interrelations?
by: A. A. Sheptulin, et al.
Published: (2010-08-01)

Colorectal Cancer in Patient with Functional Gastrointestinal Symptoms
by: Z. A. Mamieva, et al.
Published: (2022-01-01)

Management of a Female Patient with Irritable Bowel Syndrome and Somatoform Disorder
by: E. A. Trush, et al.
Published: (2023-02-01)

Nutraceuticals and Pharmaceuticals
by: E. A. Poluektova, et al.
Published: (2020-05-01)

The role of serotonin and melatonin in the development of clinical manifestations of functional gastrointestinal disorders associated with abdominal pain in children during wartime
by: N.A. Sliusar, et al.
Published: (2025-06-01)

Quality of Life and Level of Physical Activity In Students with and without Symptoms of Functional Dyspepsia and Irritable Bowel Syndrome Surveyed with Questionnaire “7×7” (7 Symptoms Per 7 Days)
by: T. V. Zhestkova
Published: (2020-07-01)

Discussion of irritable bowel syndrome issue and functional constipations in reports of the 21st United European Gastroenterological Week (Berlin, 2013)
by: A. A. Sheptulin, et al.
Published: (2014-09-01)

The Role of Motility Impairment in the Pathogenesis of Functional Disorders of the Gastrointestinal Tract and Modern Possibilities for Their Treatment (Resolution of an Expert Council and Literature Review)
by: I. V. Maev, et al.
Published: (2020-01-01)

Single Nucleotide Polymorphisms, Associated with Increased Risk of Irritable Bowel Syndrome with Predominant Constipation: A Meta Analysis
by: E. A. Trush, et al.
Published: (2024-08-01)

Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia
by: V. T. Ivashkin, et al.
Published: (2022-01-01)

The treatment of irritable bowel syndrome from the modern views on the disease pathogenesis
by: Ye. A. Poluektova, et al.
Published: (2013-03-01)

Pathogenic role of intestinal microflora changes in patients with irritable bowel syndrome and treatment options
by: Ye. A. Poluektova, et al.
Published: (2014-09-01)

Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
by: V. T. Ivashkin, et al.
Published: (2024-12-01)

Role of emotional disorders, personality features and disorders of intraceptive sensation in development of somatic symptoms at irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2013-12-01)

Continuously relapsing (for two years) course of diarrheal variant of IBS (<i>Clinical case</i>)
by: Ye. A. Poluektova, et al.
Published: (2013-10-01)

THE USE OF SPECIFIC AND NON-SPECIFIC QUESTIONNAIRES TO ASSESS QUALITY OF LIFE IN PATIENTS WITH FUNCTIONAL DISORDERS OF INTESTINE
by: A. E. Shklyaev, et al.
Published: (2016-08-01)

Comparative efficacy of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> composition and prucalopride in treatment of constipation variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-07-01)

Comparative assessment of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> and <i>Saccharomyces boulardii</i> efficacy at diarrheal variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-05-01)

Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Overlap of Two Nosological Forms or Two Variants of the Same Disease?
by: A. A. Sheptulin, et al.
Published: (2019-12-01)

Role Adaptole in Correction Neurasthenia at Patients with the Syndrome of Angry Intestines (IBS)
by: E. E. Alekseev, et al.
Published: (2012-03-01)

Combined alverine citrate and simeticonein preparation in the treatment of irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2012-07-01)

Phenotypes of irritable bowel syndrome and strategies for patient-oriented curation of patient
by: O. V. Gaus, et al.
Published: (2023-08-01)

New Approaches to Therapy of the Irritated Bowel Syndrome
by: N. V. Korochanskaya, et al.
Published: (2012-03-01)

ДИНАМИКА КАЧЕСТВА ЖИЗНИ ПАЦИЕНТОВ С СИНДРОМОМ РАЗДРАЖЕННОГО КИШЕЧНИКА В ПРОЦЕССЕ МЕДИКАМЕНТОЗНОЙ И НЕМЕДИКАМЕНТОЗНОЙ ТЕРАПИИ
by: А. Е. Шкляев, et al.
Published: (2015-04-01)

VISUAL ASSESSMENT OF THE MUCOSA OF THE COLON IN IRRITABLE BOWEL SYNDROME IN THE DYNAMICS OF TREATMENT
by: A. E. Shklyaev, et al.
Published: (2016-12-01)

Spa Treatment of Irratable Bowel Syndrome
by: L. H. Bolatchieva, et al.
Published: (2012-09-01)

Discussion of the problem of functional constipation and irritable bowel syndrome in the reports of the International Congress on Neurogastroenterology and Motility (Bologna, 2012)
by: A. A. Sheptulin, et al.
Published: (2013-03-01)

COVID-19 Pandemic and IBS. Results of the All-Russian Observational Non-interventional Program to Study the Effectiveness of the Drug Kolofort® in Real Clinical Practice in Patients with Irritable Bowel Syndrome After a New Coronavirus Infection (VESNA)
by: V. T. Ivashkin, et al.
Published: (2023-12-01)

The Use of L-Menthol in Endoscopic Transpapillary Interventions. Prospective Randomized Dual-Center Study
by: M. A. Anishchenko, et al.
Published: (2023-12-01)

STUDY OF THE SAFETY OF ANTIANEMIC PREPARATIONS BY METHOD OF THE SYSTEM OF PROBLEMS RELATED TO MEDICINAL PREPARATIONS
by: A. V. Matveev, et al.
Published: (2021-06-01)

Validation of Analytical Methods of Several Secondary Metabolic Compounds in Andrographis paniculata, Zingiber officinale var. rubrum, and Nigella sativa as COVID-19 Therapy: A Review
by: Farendina Suarantika, et al.
Published: (2022-03-01)

Probiotics in the Complex Treatment of Various Diseases of the Gastrointestinal Tract
by: K. V. Ivashkin, et al.
Published: (2020-04-01)

Efficiency of butyric acid and inulin in patients with irritable bowels syndrome: results of multicenter study
by: S. V. Levchenko, et al.
Published: (2021-06-01)

Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
by: A. A. Sheptulin, et al.
Published: (2022-03-01)